Pharvaris BV
PHVS
Insider trades and stock quote 2024-2026
All insider trades at Pharvaris BV
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
7/13/2026
|
Sell |
Modig, Berndt |
Chief Executive Officer |
$35.0 |
$80,154 |
|
6/30/2026
|
Sell |
Lesage, Anne |
Chief Early Development |
$35.5 |
$2,078,527 |
|
6/30/2026
|
Sell |
Schikan, Johannes Gerardus Christiaan Petrus |
Director |
$35.5 |
$1,090,049 |
|
6/29/2026
|
Sell |
Lesage, Anne |
Chief Early Development |
$35.1 |
$616,926 |
|
6/29/2026
|
Sell |
Schikan, Johannes Gerardus Christiaan Petrus |
Director |
$35.1 |
$325,697 |
|
6/26/2026
|
Sell |
Lu, Peng |
Chief Medical Officer |
$34.0 |
$499,847 |
|
6/25/2026
|
Sell |
Lu, Peng |
Chief Medical Officer |
$34.8 |
$518,985 |
|
6/25/2026
|
Sell |
Lesage, Anne |
Chief Early Development |
$35.1 |
$161,561 |
|
6/18/2026
|
Sell |
Lu, Peng |
Chief Medical Officer |
$34.0 |
$10,200 |
|
6/15/2026
|
Sell |
Modig, Berndt |
Chief Executive Officer |
$31.2 |
$71,173 |
|
6/4/2026
|
Sell |
Nijdam, Anna |
Principal Accounting Officer |
$30.9 |
$82,425 |
|
5/22/2026
|
Sell |
Nijdam, Anna |
Principal Accounting Officer |
$30.7 |
$169,084 |
|
5/21/2026
|
Sell |
Nassif, David W. |
CFO / CLO |
$30.3 |
$303,076 |
|
5/21/2026
|
Sell |
Nijdam, Anna |
Principal Accounting Officer |
$30.6 |
$55,971 |
|
5/21/2026
|
Sell |
Monges, Viviane |
Director |
$30.3 |
$292,853 |
|
5/20/2026
|
Sell |
Bjork, Elisabeth |
Director |
$29.3 |
$293,166 |
|
5/18/2026
|
Sell |
Modig, Berndt |
Chief Executive Officer |
$29.2 |
$66,977 |
|
5/15/2026
|
Sell |
Souverijns, Wim |
Chief Commercial Officer |
$29.9 |
$299,163 |
|
5/15/2026
|
Sell |
Abele, Stefan Andreas |
Chief Technical Ops Officer |
$29.8 |
$260,864 |
|
5/15/2026
|
Sell |
Glassman, Robert |
Director |
$29.8 |
$298,246 |
|
5/1/2026
|
Sell |
Lu, Peng |
Chief Medical Officer |
$30.6 |
$427,419 |
|
4/30/2026
|
Sell |
Lu, Peng |
Chief Medical Officer |
$30.2 |
$453,627 |
|
4/30/2026
|
Sell |
Lesage, Anne |
Chief Early Development |
$30.3 |
$1,237,459 |
|
4/30/2026
|
Sell |
Schikan, Johannes Gerardus Christiaan Petrus |
Director |
$30.7 |
$881,380 |
|
4/29/2026
|
Sell |
Lu, Peng |
Chief Medical Officer |
$30.1 |
$112,232 |
|
4/29/2026
|
Sell |
Lesage, Anne |
Chief Early Development |
$30.1 |
$222,509 |
|
4/29/2026
|
Sell |
Schikan, Johannes Gerardus Christiaan Petrus |
Director |
$30.1 |
$115,165 |
|
4/23/2026
|
Sell |
Lu, Peng |
Chief Medical Officer |
$30.0 |
$3,003 |
|
4/23/2026
|
Sell |
Lesage, Anne |
Chief Early Development |
$30.0 |
$6,006 |
|
4/23/2026
|
Sell |
Schikan, Johannes Gerardus Christiaan Petrus |
Director |
$30.0 |
$3,003 |
|
4/22/2026
|
Sell |
Lu, Peng |
Chief Medical Officer |
$30.1 |
$210,402 |
|
4/22/2026
|
Sell |
Lesage, Anne |
Chief Early Development |
$30.0 |
$435,720 |
|
4/22/2026
|
Sell |
Schikan, Johannes Gerardus Christiaan Petrus |
Director |
$30.1 |
$210,379 |
|
4/16/2026
|
Sell |
Modig, Berndt |
Chief Executive Officer |
$28.6 |
$65,559 |
|
4/9/2026
|
Sell |
Modig, Berndt |
Chief Executive Officer |
$28.1 |
$647,281 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Insidertrades in Telegram
Follow insider buying in real time via push in our Telegram channel.
Join now